Search research articles
Contact Us
Filters
Showing results (281-290 of 1,221) with videos related to
Page
of 123
Sort By:
Joint Commission Journal on Quality and Patient Safety
|
February 14, 2009
Using implementation safety indicators for CPOE implementation
Charlene R Weir, Cynthia A McCarthy
Postgraduate Medicine
|
February 15, 1992
Risk for renal injury in diabetic hypertensive patients. The physiologic basis for blood pressure control
M R Weir, G L Bakris
Postgraduate Medicine
|
February 15, 1992
Risk for renal injury in diabetic hypertensive patients. Pharmacologic approaches
M R Weir, G L Bakris
Sub-Cellular Biochemistry
|
July 7, 2007
COX-2 inhibitors and cardiovascular risk
Daniel J Salzberg, Matthew R Weir
Current Hypertension Reports
|
August 13, 2010
Does blockade of the Renin-Angiotensin-aldosterone system slow progression of all forms of kidney disease?
Michael R Lattanzio, Matthew R Weir
Current Hypertension Reports
|
August 21, 2010
Optimal blood pressure for a patient with type 2 diabetes mellitus: insight from the ACCORD study
Matthew R Weir, George L Bakris
Primary Care
|
September 1, 1991
Hypertension and the kidney
M R Weir, S D Wolfsthal
Clinical Therapeutics
|
January 27, 2009
Antihypertensive efficacy and tolerability of irbesartan/hydrochlorothiazide in hypertensive patients stratified by body mass index and type 2 diabetes mellitus status: a post hoc subgroup analysis of the Irbesartan/HCTZ Blood Pressure Reductions in Diverse Patient Populations trial
Andrew J Lewin, Matthew R Weir
Current Opinion in Nephrology and Hypertension
|
March 28, 2014
Safety of medical therapy in patients with chronic kidney disease and end-stage renal disease
Matthew R Weir, Jeffrey C Fink
The American Journal of Medicine
|
October 1, 1985
Extrapulmonary tuberculosis. Experience of a community hospital and review of the literature
M R Weir, G F Thornton
Page
of 123
Search research articles
Search
Showing results (281-290 of 1,221) with videos related to
Sort By:
Page
of 123
Joint Commission Journal on Quality and Patient Safety
|
February 14, 2009
Using implementation safety indicators for CPOE implementation
Charlene R Weir, Cynthia A McCarthy
Postgraduate Medicine
|
February 15, 1992
Risk for renal injury in diabetic hypertensive patients. The physiologic basis for blood pressure control
M R Weir, G L Bakris
Postgraduate Medicine
|
February 15, 1992
Risk for renal injury in diabetic hypertensive patients. Pharmacologic approaches
M R Weir, G L Bakris
Sub-Cellular Biochemistry
|
July 7, 2007
COX-2 inhibitors and cardiovascular risk
Daniel J Salzberg, Matthew R Weir
Current Hypertension Reports
|
August 13, 2010
Does blockade of the Renin-Angiotensin-aldosterone system slow progression of all forms of kidney disease?
Michael R Lattanzio, Matthew R Weir
Current Hypertension Reports
|
August 21, 2010
Optimal blood pressure for a patient with type 2 diabetes mellitus: insight from the ACCORD study
Matthew R Weir, George L Bakris
Primary Care
|
September 1, 1991
Hypertension and the kidney
M R Weir, S D Wolfsthal
Clinical Therapeutics
|
January 27, 2009
Antihypertensive efficacy and tolerability of irbesartan/hydrochlorothiazide in hypertensive patients stratified by body mass index and type 2 diabetes mellitus status: a post hoc subgroup analysis of the Irbesartan/HCTZ Blood Pressure Reductions in Diverse Patient Populations trial
Andrew J Lewin, Matthew R Weir
Current Opinion in Nephrology and Hypertension
|
March 28, 2014
Safety of medical therapy in patients with chronic kidney disease and end-stage renal disease
Matthew R Weir, Jeffrey C Fink
The American Journal of Medicine
|
October 1, 1985
Extrapulmonary tuberculosis. Experience of a community hospital and review of the literature
M R Weir, G F Thornton
Page
of 123